Hims & Hers Health Inc
NYSE:HIMS

Watchlist Manager
Hims & Hers Health Inc Logo
Hims & Hers Health Inc
NYSE:HIMS
Watchlist
Price: 30.56 USD 8.56% Market Closed
Market Cap: $7B

EV/OCF

24.5
Current
22%
Cheaper
vs 3-y average of 31.6

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
24.5
=
Enterprise Value
$3.7B
/
Operating Cash Flow
$300m

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
24.5
=
Enterprise Value
$3.7B
/
Operating Cash Flow
$300m

Valuation Scenarios

Hims & Hers Health Inc is trading below its 3-year average

If EV/OCF returns to its 3-Year Average (31.6), the stock would be worth $39.4 (29% upside from current price).

Statistics
Positive Scenarios
1/4
Maximum Downside
-32%
Maximum Upside
+29%
Average Downside
9%
Scenario EV/OCF Value Implied Price Upside/Downside
Current Multiple 24.5 $30.56
0%
3-Year Average 31.6 $39.4
+29%
5-Year Average 21.8 $27.23
-11%
Industry Average 18.7 $23.3
-24%
Country Average 16.7 $20.81
-32%

Forward EV/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward EV/OCF

Peer Comparison

All Multiples
EV/OCF
P/E
All Countries
Close
Market Cap EV/OCF P/E
US
Hims & Hers Health Inc
NYSE:HIMS
6.9B USD 24.5 54.1
US
CVS Health Corp
NYSE:CVS
99.1B USD 14 56
US
Cigna Group
XMUN:CGN
69.7B EUR 10.7 13.5
US
Cigna Corp
NYSE:CI
72.6B USD 0 12.2
DE
Fresenius Medical Care AG
XMUN:FME
23.1B EUR 11.1 23.6
DE
Fresenius SE & Co KGaA
XETRA:FRE
22.7B EUR 12.3 17.9
US
Quest Diagnostics Inc
NYSE:DGX
21.8B USD 14.4 21.4
US
Laboratory Corporation of America Holdings
NYSE:LH
21.7B USD 15.9 24.7
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.8B EUR 6.5 11.1
US
Guardant Health Inc
NASDAQ:GH
11.6B USD -65.6 -27.9
US
DaVita Inc
NYSE:DVA
10.4B USD 10.4 13.9

Market Distribution

Higher than 72% of companies in the United States of America
Percentile
72nd
Based on 9 518 companies
72nd percentile
24.5
Low
0 — 11.7
Typical Range
11.7 — 23.6
High
23.6 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 11.7
Median 16.7
70th Percentile 23.6
Max 3 178 983.5

Hims & Hers Health Inc
Glance View

Once upon a time in the bustling landscape of telehealth services, Hims & Hers Health Inc. emerged as a pioneering force, reshaping the narrative around personal wellness and healthcare accessibility. Founded with a direct-to-consumer approach, the company cleverly positioned itself at the intersection of convenience and necessity. Operating primarily through an online platform, Hims & Hers offers a range of health-related products and services targeting conditions often stigmatized or considered sensitive, such as hair loss, erectile dysfunction, skincare, mental health, and more. The company’s business model hinges on its ability to bypass traditional healthcare barriers, providing easy access to licensed healthcare professionals and personalized treatment plans through a seamless internet-based interface. Their revenue model is multifaceted, but at its core are product sales and subscription services. Customers begin their journey by completing a brief online consultation, which, in many states, can involve a healthcare professional reviewing their information without an in-person visit. Once approved, the company's network of telehealth providers prescribes medications, which are conveniently delivered to customers’ doorsteps. Whether purchasing single products or opting for monthly subscriptions, users are drawn to the discretion and accessibility of the service. Hims & Hers markets its offerings directly through savvy digital campaigns, leveraging the power of modern e-commerce to reach younger demographics who appreciate privacy and efficiency in managing their health. Thus, the company stands as a compelling example of how technology can democratize healthcare, wrapped seamlessly within the bounds of consumer-friendly digital infrastructure.

HIMS Intrinsic Value
23.17 USD
Overvaluation 24%
Intrinsic Value
Price $30.56
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett